OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 63 filers reported holding OVID THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | -97.5% | 26,831 | -96.4% | 0.01% | -96.4% |
| Q1 2022 | $2,319,000 | +2.4% | 738,372 | +4.7% | 0.30% | -9.5% |
| Q4 2021 | $2,264,000 | -39.1% | 705,082 | -36.2% | 0.34% | +28.6% |
| Q3 2021 | $3,715,000 | -15.5% | 1,105,082 | -1.8% | 0.26% | -26.4% |
| Q2 2021 | $4,398,000 | -2.7% | 1,124,872 | 0.0% | 0.36% | +134.2% |
| Q1 2021 | $4,522,000 | +4815.2% | 1,124,872 | +6930.4% | 0.15% | +2071.4% |
| Q3 2020 | $92,000 | -91.8% | 16,000 | -95.8% | 0.01% | -91.8% |
| Q1 2020 | $1,126,000 | -22.5% | 377,737 | +7.9% | 0.08% | -63.8% |
| Q4 2019 | $1,453,000 | – | 350,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |